Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06788912 |
| Title | Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) |
| Acronym | KEYMAKER-U01 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| MedStar Franklin Square Medical Center ( Site 0033) | RECRUITING | Baltimore | Maryland | 21237 | United States | Details |
| Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150) | RECRUITING | Gdansk | Pomorskie | 80-952 | Poland | Details |